BCL9 and neoplasm: We found that XCL1 expression by intratumoral CD8+ T cells was upregulated in hsBCL9z96-treated CT26 tumor-bearing mice and MC38 tumor-bearing Bcl9/Bcl9l deficiency mice (Fig. 6g, h).